PDK1 and central nervous system cancer: The inhibition of PDK1 with DCA has been investigated in several clinical trials, including trials for glioma and refractory metastatic breast cancer (ClinicalTrials.gov Identifier: NCT01111097, NCT01386632, and NCT01029925)31.